DNLI
Denali Therapeutics Inc.
$15.27
-$0.38(-2.43%)
42
Overall
--
Value
40
Tech
44
Quality
Market Cap
$2.27B
Volume
1.89M
52W Range
$10.57 - $33.33
Target Price
$32.20
EPS Estimates Overview
| Current Quarter | $-0.77 | Next Quarter | $-0.78 |
| Current Year | $-3.05 | Next Year | $-2.94 |
| QoQ Growth | -1.3% | YoY Growth | +3.6% |
| 3Y EPS CAGR | -1.8% | Target Price | $32.20 |
| Consensus | Buy | Upside | +110.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $15.27 | -2.4% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW